Table 2:

Comparison of DTI parameter values among HC, the total cohort of patients (including MS and other cause of inflammatory myelopathy), and different subgroups of patients

	HC vs Total Cohort	Patients without Acute Cervical Lesions			HC vs Patients with Acute Cervical Lesions
	HC vs Total Cohort	HC vs (MS + Other)	HC vs MS	HC vs Other	HC vs Patients with Acute Cervical Lesions
FA (10⁻³ mm²/s)	P = .001^{^a,^b}	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P = 0.091
MD (10⁻³ mm²/s)	P = .131	P = .002^{^a}	P < .0001^{^a,^b}	P = .025^{^a}	P < .0001^{^a,^b}
E1 (10⁻³ mm²/s)	P = .610	P = .075	P = .011^{^a}	P = .432	P < .0001^{^a,^b}
E2 (10⁻³ mm²/s)	P = .014^{^a}	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P = .005^{^a}	P < .0001^{^a,^b}
E3 (10⁻³ mm²/s)	P = .056	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P = .012^{^a}	P < .0001^{^a,^b}
rD (10⁻³ mm²/s)	P = .040^{^a}	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P = .003^{^a}	P < .0001^{^a,^b}
Ratio	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P < .0001^{^a,^b}	P = .005^{^a}	P = .291

↵a Significant P values.
↵b P values remaining significant (P < .05) after Bonferroni correction.